Literature DB >> 21734192

Systems analysis of GLP-1 receptor signaling in pancreatic β-cells.

Yukari Takeda1, Akira Amano, Akinori Noma, Yasuhiko Nakamura, Shimpei Fujimoto, Nobuya Inagaki.   

Abstract

Glucagon-like peptide-1 (GLP-1) elevates intracellular concentration of cAMP ([cAMP]) and facilitates glucose-dependent insulin secretion in pancreatic β-cells. There has been much evidence to suggest that multiple key players such as the GLP-1 receptor, G(s) protein, adenylate cyclase (AC), phosphodiesterase (PDE), and intracellular Ca(2+) concentration ([Ca(2+)]) are involved in the regulation of [cAMP]. However, because of complex interactions among these signaling factors, the kinetics of the reaction cascade as well as the activities of ACs and PDEs have not been determined in pancreatic β-cells. We have constructed a minimal mathematical model of GLP-1 receptor signal transduction based on experimental findings obtained mostly in β-cells and insulinoma cell lines. By fitting this theoretical reaction scheme to key experimental records of the GLP-1 response, the parameters determining individual reaction steps were estimated. The model reconstructed satisfactorily the dynamic changes in [cAMP] and predicted the activities of cAMP effectors, protein kinase A (PKA), and cAMP-regulated guanine nucleotide exchange factor [cAMP-GEF or exchange protein directly activated by cAMP (Epac)] during GLP-1 stimulation. The simulations also predicted the presence of two sequential desensitization steps of the GLP1 receptor that occur with fast and very slow reaction rates. The cross talk between glucose- and GLP-1-dependent signal cascades for cAMP synthesis was well reconstructed by integrating the direct regulation of AC and PDE by [Ca(2+)]. To examine robustness of the signaling system in controlling [cAMP], magnitudes of AC and PDE activities were compared in the presence or absence of GLP-1 and/or the PDE inhibitor IBMX.(1).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734192     DOI: 10.1152/ajpcell.00057.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction.

Authors:  Y Diz-Chaves; L Toba; J Fandiño; L C González-Matías; L M Garcia-Segura; F Mallo
Journal:  J Neuroinflammation       Date:  2018-12-05       Impact factor: 8.322

2.  Rp-cAMPS Prodrugs Reveal the cAMP Dependence of First-Phase Glucose-Stimulated Insulin Secretion.

Authors:  Frank Schwede; Oleg G Chepurny; Melanie Kaufholz; Daniela Bertinetti; Colin A Leech; Over Cabrera; Yingmin Zhu; Fang Mei; Xiaodong Cheng; Jocelyn E Manning Fox; Patrick E MacDonald; Hans-G Genieser; Friedrich W Herberg; George G Holz
Journal:  Mol Endocrinol       Date:  2015-06-10

Review 3.  New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout mice.

Authors:  George G Holz; Colin A Leech; Oleg G Chepurny
Journal:  Biochim Biophys Acta       Date:  2014-06-27

Review 4.  Assessing the Effect of Incretin Hormones and Other Insulin Secretagogues on Pancreatic Beta-Cell Function: Review on Mathematical Modelling Approaches.

Authors:  Giovanni Pacini; Bo Ahrén; Christian Göbl; Andrea Tura
Journal:  Biomedicines       Date:  2022-05-03

Review 5.  New insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells: the involvement of the Wnt signaling pathway effector β-catenin.

Authors:  Xiaoquan Xiong; Weijuan Shao; Tianru Jin
Journal:  Islets       Date:  2012-11-01       Impact factor: 2.694

6.  Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational Analysis.

Authors:  Leonid E Fridlyand; Louis H Philipson
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

Review 7.  Cyclic AMP dynamics in the pancreatic β-cell.

Authors:  Anders Tengholm
Journal:  Ups J Med Sci       Date:  2012-09-13       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.